Prepregnancy Cardiovascular Optimization May Help Mitigate Maternal Death Risk Disparities
The stark reality that heart disease kills more pregnant women than any other cause in America reveals a preventable…
The stark reality that heart disease kills more pregnant women than any other cause in America reveals a preventable…
The expanding use of newborn screening is revealing a puzzling metabolic condition where biochemical abnormalities…
The promise of widespread mammographic screening appears incomplete as new data reveals a troubling reality: advanced…
The discovery that cancer cells can hijack embryonic development programs represents a critical advance in…
The menopausal transition marks a critical window where hormonal shifts trigger metabolic changes that predispose…
The brain's ability to clear toxic waste products during sleep may hold the key to preventing neurodegenerative…
The timing of when diabetes patients receive advanced treatments may fundamentally alter their long-term trajectory…
The midlife hormonal transition creates a perfect storm for women already struggling with migraine, potentially…
The discovery that pancreatic tumors hijack nerve development pathways could reshape treatment strategies for one of…
The clinical paradox of withholding antibiotics during cancer immunotherapy may need fundamental reconsideration, as…
Nearly one in four postmenopausal women with existing heart disease will die from cardiovascular causes within a…
Medical research increasingly requires combining data from multiple hospitals and health systems to achieve meaningful…
Severely ill COVID-19 patients may not benefit from expensive monoclonal antibody treatments, challenging assumptions…
The psychological aftermath of traumatic injuries may be receiving inadequate attention in standard follow-up care…
Valley fever represents one of the most underappreciated threats to human health in the American Southwest, where…
Lung cancer patients face a critical dilemma: radiation therapy powerful enough to destroy tumors often damages…
A systematic review of 28 clinical studies reveals that growth hormone therapy demonstrates beneficial effects on…
Patients receiving GLP-1 receptor agonists (primarily liraglutide and semaglutide) for an average of 21.7 weeks before…
GLP-1 receptor agonists demonstrate measurable reductions in hepatic steatosis, inflammation, and fibrosis biomarkers…
Tirzepatide's effectiveness varies dramatically between individuals based on clinical factors like diabetes duration…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.